Tag: SBLK

Blue Horseshoe Stocks: KMX Options Update & More

CarMax, Inc. KMX – Options Idea

We formulated several targets in the KMX options chain yesterday morning in accordance with the solid earnings beat and premarket gap-up we were observing.   We specified some medium and longer-term contracts with the KMX C$57.50 and $60 Calls, and the 05/19 $60-$65 Calls. We were more than pleased with the activity that ensued.

We’re usually pretty good with our targeting, and these ideas were no exception. Every single one of the contracts we mentioned provided traders with the chance for some very nice single-session gains.

04/21 $57.50 Calls – Range: .45-1.70 – Max Gain: 278%
04/21 $60 Calls – Range:  .17-.75 – Max Gain: 341%

05/19 $60 Calls – Range: .68-1.54 – Max Gain: 126%
05/19 $62.50 Calls – Range: .28-.82- Max Gain: 193%
05/19 $65 Calls – Range: .11-.38 – Max Gain: 245%

With that kind of activity on the very first day, we’re definitely going to want to keep these plays in mind going forward. There may yet be more opportunities still to come.

Akari Therapeutics, Plc. AKTX

We tagged AKTX in yesterday morning’s extended watchlist and saw a very nice intraday performance. It traded in a daily range from a low of 13.69 to a high of 18.46, which represents a 35% spike on the day.

That move came on more than thirteen times the three-month average volume. On the whole, the activity in AKTX was extremely impressive, especially for a stock in its price range. The stock failed to maintain the majority of its daily advance, but we’ll remain interested provided it can register a higher base level of support to close out the week today.


In Ovations Holdings, Inc. INOH

We’re going to begin monitoring this super-subpenny stock after it just reappeared with its first filings in quite some time; two quarterlies and an annual report can be found at the company’s OTC Market filings page (>>View Filings). The filings bring the company current on its financial reporting.

We’ve seen a number of triple-zero stocks make exponential gains in recent weeks, and want to take a flyer on INOH on the outside chance that it could be the next rocket to leave the launchpad!

Extended Watchlist:
GBSN, CLNT, MNKD, SALT, SBLK, CBR,

Blue Horseshoe Stocks: Week Kicks Off on High Note


Yesterday, despite the fact that the markets as a whole were on pace for the longest sustained backslide in more than half a decade, we still managed to see new highs in a few of the stocks we’ve been tracking.  We also observed solid intraday performances from a couple other plays that were on our morning watchlist, so we’ll begin today with a quick roundup of all these movers.

Dolat Ventures, Inc. DOLV

We signaled our interest in tracking DOLV in Thursday’s report, and at the time we’d witness the stock trading at a low of .0056.

Yesterday concluded with a new high, and the recording of three straight bullish sessions since then, with DOLV trading in an intraday range from .0125 to .019, for a gain of 52% It brings the updated figure on the three session swing we’ve seen so far to an impressive 239%

MyDx, Inc. MYDX

We circled back to MYDX, a stock we’ve tracked all the way from a February low of .001, last Wednesday, while it was trading as low as .0077. It too has put together a multi-day run leading to impressive new highs once again yesterday.

The stock saw a daily range of .017-.0226, which represents an increase of 32% on the day, 193% from last Wednesday’s low, and a ridiculous 2160% from our witnessed low in February!

U.S. Stem Cell, Inc. USRM

Here’s another stock whose low (.014) came during the month of February, following our report on the 27th. We’ve been all over it since then , and in two sustained bursts it has absolutely soared.

After reminding our readers of that fact in yesterday’s premarket report, USRM managed to hit yet another new high for us. It traded from .07-.112 for a daily boost of 60% and the new high recorded pushed our overall observed gain on this play in just one months time to an even 700%

Honorable Mentions

We placed a couple of plays in yesterday’s extended watchlist that didn’t blow our minds by any stretch of the imagination, but did log some solid intraday increases that warrant continued observation for each of them.

Catalyst Pharmaceuticals, Inc. CPRX
Daily Range: 1.63-2.07 – Max Gain: 27%

Impax Laboratories, Inc. IPXL
Daily Range: 10.50-13.00 – Max Gain: 24%

Extended Watchlist:
BRSE, OWCP, CARA, NVIV, SHIP, SSH, SBLK